Tecan Group (TCHB.F) Stock Overview
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
TCHB.F Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Tecan Group AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 175.75 |
| 52 Week High | CHF 211.90 |
| 52 Week Low | CHF 155.25 |
| Beta | 1.11 |
| 1 Month Change | 12.44% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -59.77% |
| 5 Year Change | -63.36% |
| Change since IPO | 480.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| TCHB.F | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 0% | -6.4% | -0.2% |
| 1Y | n/a | 1.0% | 27.6% |
Return vs Industry: Insufficient data to determine how TCHB.F performed against the US Life Sciences industry.
Return vs Market: Insufficient data to determine how TCHB.F performed against the US Market.
Price Volatility
| TCHB.F volatility | |
|---|---|
| TCHB.F Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 8.1% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: TCHB.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine TCHB.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 3,166 | Monica Manotas | www.tecan.com |
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution.
Tecan Group AG Fundamentals Summary
| TCHB.F fundamental statistics | |
|---|---|
| Market cap | US$1.83b |
| Earnings (TTM) | -US$139.88m |
| Revenue (TTM) | US$1.12b |
Is TCHB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TCHB.F income statement (TTM) | |
|---|---|
| Revenue | CHF 882.48m |
| Cost of Revenue | CHF 571.64m |
| Gross Profit | CHF 310.84m |
| Other Expenses | CHF 421.49m |
| Earnings | -CHF 110.65m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Aug 11, 2026
| Earnings per share (EPS) | -8.83 |
| Gross Margin | 35.22% |
| Net Profit Margin | -12.54% |
| Debt/Equity Ratio | 13.1% |
How did TCHB.F perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/30 07:26 |
| End of Day Share Price | 2026/04/17 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Tecan Group AG is covered by 21 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Leonildo Delgado | Baader Helvea Equity Research |
| Volker Bosse | Baader Helvea Equity Research |
| Markus Mayer | Baader Helvea Equity Research |